Which of the following best describes the primary mechanism of action of Beta-lactam antibiotics (such as penicillins)?
In traditional classification frameworks or specific resistance categorization systems, Antibiotic Class A resistance typically involves which of the following resistance
Which antibiotic class targets bacterial protein synthesis by binding reversibly to the 50S ribosomal subunit, preventing peptide bond formation?
Antibiotics classified under Class B beta-lactamases are distinct because they are:
Which of the following is a classic example of an antibiotic belonging to the fluoroquinolone class?
Antibiotic Class C resistance genes (such as chromosomal or plasmid-mediated ampC) commonly confer resistance to which of the following groups?
Aminoglycosides (e.g., Gentamicin, Tobramycin) primarily target which bacterial structure?
Why are antibiotics ineffective against viral infections like the common cold or influenza?
Which class acts by binding to the bacterial 30S ribosomal subunit?
Which class commonly binds to the bacterial 50S ribosomal subunit?
Explanation
Beta-lactam mechanism: They bind to penicillin-binding proteins (PBPs), halting cell wall cross-linking and causing osmotic cell lysis.
The Ambler classification system categorizes beta-lactamases based on their molecular structure. Class A enzymes are serine-active beta-lactamases that include classic plasmid-mediated enzymes like TEM and SHV, alongside modern Extended-Spectrum Beta-Lactamases (ESBLs) like CTX-M that confer resistance to broad-spectrum cephalosporins.
Macrolides exert their bacteriostatic effects by binding reversibly to the 23S rRNA of the 50S ribosomal subunit. This blocks the polypeptide exit tunnel, stopping peptide chain elongation and halting bacterial protein synthesis.
Class B beta-lactamases are unique metallo-enzymes that utilize active-site zinc ions to facilitate the hydrolysis of the beta-lactam ring. Because their catalytic mechanism relies on metal ions rather than a serine residue, standard serine-based inhibitors like clavulanic acid are completely ineffective against them.
Ciprofloxacin is a well-known second-generation fluoroquinolone used for a wide range of bacterial infections. The other choices belong to distinct classes: doxycycline is a tetracycline, vancomycin is a glycopeptide, and trimethoprim-sulfamethoxazole is an antifolate combination.
Class C beta-lactamases (frequently called AmpC enzymes) are chromosomal or plasmid-driven enzymes that efficiently break down penicillins, early-generation cephalosporins, and cephamycins. Like Class B enzymes, they generally evade inhibition by standard clavulanic acid.
Aminoglycosides (such as gentamicin and tobramycin) bind irreversibly to the 30S ribosomal subunit. This alters the conformation of the decoding region, causing the bacterial ribosome to misread mRNA codons and synthesize nonfunctional, toxic proteins.
Antibiotics are engineered to target distinct prokaryotic structures (like peptidoglycan walls or 70S bacterial ribosomes). Viruses are acellular infectious particles that lack these independent structures, relying entirely on host cell machinery instead.
The primary clinical defense mechanism against aminoglycosides involves bacterial aminoglycoside-modifying enzymes (AMEs). These enzymes alter the chemical structure of the antibiotic through acetylation, phosphorylation, or adenylation, preventing it from binding to its target site on the ribosome.
Fluoroquinolones penetrate bacterial cells and target critical topoisomerase enzymes—specifically DNA gyrase (topoisomerase II), which relieves DNA supercoiling during replication, and topoisomerase IV, which separates daughter chromosomes. Inhibiting these enzymes quickly halts bacterial DNA synthesis.